Latest news
Voyager Therapeutics (VYGR) Stock Rebounds While Cash Runway Concerns Persist - simplywall.stsimplywall.st · Sat, 08 Aug 2026 04:49:06 GMTIs Voyager Therapeutics Inc (VYGR) Overvalued After Q2 Earnings - GuruFocusGuruFocus · Fri, 07 Aug 2026 08:01:34 GMTVoyager Therapeutics (VYGR) Reports Q2 Loss, Misses Revenue Estimates - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 23:10:27 GMTVYGR Looks 86.3% Overvalued on GF Value™ - GuruFocusGuruFocus · Thu, 06 Aug 2026 22:34:50 GMTVoyager Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Thu, 06 Aug 2026 20:43:31 GMTVoyager Therapeutics reports Q2 2026 net loss $24.5M, cash $148.8M; runway into 2028 - TradingViewTradingView · Thu, 06 Aug 2026 20:13:22 GMTVoyager Therapeutics Q2 collaboration revenue falls, net loss narrows - TradingViewTradingView · Thu, 06 Aug 2026 20:13:16 GMTVoyager Reports Second Quarter 2026 Financial and Operating Results - GlobeNewswireGlobeNewswire · Thu, 06 Aug 2026 20:01:00 GMT